Gapping up
In reaction to earnings/guidance:
- RRR +8.4%, TMUS +7.7%, CCS +7.4%, CHNG +6%, WD +6%, AZEK +5.3%, VSTO +4.4%, EGHT +3.3%, WEC +2.9%, SKY +2.7%, PBH +2.7%, HBI +2.4%, ABMD +2.3%, MTG +2.2%, MCK +1.6%, MXL +1.6%, ICE +1.5%, BDX +1.3%, INGR +0.8%, PH +0.8%, CHKP +0.7%, NS +0.7%
Other news:
- FLEX +6.6% (to sell $500 mln of convertible preferred equity in Nextracker to TPG Rise Climate)
- SYRS +5.7% (FDA grants orphan drug designation for tamibarotene)
- ZEV +4.8% (reached an agreement with General Motors (GM) to be the first GM Specialty Vehicle Manufacturer to provide fully electric Class 3 through Class 6 commercial vehicles)
Analyst comments:
- CHRW +0.5% (upgraded to Buy from Hold at Stifel)